Back to Search

MICHAEL PULSIPHER, M.D.

M.D.

Pediatric Hematology & Oncology Physician

NPI: 1932150315Individual

Specialties, Licenses & Credentials

Internal Medicine Physician

Internal Medicine

Code: 207R00000X

357548-1205(UT)
Hematology & Oncology Physician

Internal Medicine — Hematology & Oncology

Code: 207RH0003X

357548-1205(UT)
Pediatrics Physician

Pediatrics

Code: 208000000X

357548-1205(UT)
Pediatric Hematology & Oncology PhysicianPrimary

Pediatrics — Pediatric Hematology-Oncology

Code: 2080P0207X

357548-1205(UT)

Research & Publications (20)

Allogeneic transplantation for pediatric acute lymphoblastic leukemia: the emerging role of peritransplantation minimal residual disease/chimerism monitoring and novel chemotherapeutic, molecular, and immune approaches aimed at preventing relapse.
PMID 19147081·Biol Blood Marrow Transplant·2009
6-review
Reduced-intensity allogeneic transplantation in pediatric patients ineligible for myeloablative therapy: results of the Pediatric Blood and Marrow Transplant Consortium Study ONC0313.
PMID 19528536·Blood·2009
3-trial
Weighing the risks of G-CSF administration, leukopheresis, and standard marrow harvest: ethical and safety considerations for normal pediatric hematopoietic cell donors.
PMID 16411207·Pediatr Blood Cancer·2006
6-review
Safety and efficacy of allogeneic PBSC collection in normal pediatric donors: the pediatric blood and marrow transplant consortium experience (PBMTC) 1996-2003.
PMID 15608659·Bone Marrow Transplant·2005
8-other
Treatment of CML in pediatric patients: should imatinib mesylate (STI-571, Gleevec) or allogeneic hematopoietic cell transplant be front-line therapy?
PMID 15382266·Pediatr Blood Cancer·2004
6-review
Maintenance loses its innocence.
PMID 19520809·Blood·2009
8-other
Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program.
PMID 19190248·Blood·2009
8-other
Donor, recipient, and transplant characteristics as risk factors after unrelated donor PBSC transplantation: beneficial effects of higher CD34+ cell dose.
PMID 19608747·Blood·2009
3-trial
Long-term outcome of patients with multiple myeloma after autologous hematopoietic cell transplantation and nonmyeloablative allografting.
PMID 19015394·Blood·2009
3-trial
Lower hospital mortality and complications after pediatric hematopoietic stem cell transplantation.
PMID 18091550·Crit Care Med·2008
8-other
Hematopoietic cell transplantation-comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation.
PMID 18311781·Cancer·2008
8-other
Donor leukocyte infusions to treat hematologic malignancy relapse following allo-SCT in a pediatric population.
PMID 18490913·Bone Marrow Transplant·2008
8-other
Comparison of outcomes of HLA-matched related, unrelated, or HLA-haploidentical related hematopoietic cell transplantation following nonmyeloablative conditioning for relapsed or refractory Hodgkin lymphoma.
PMID 18940683·Biol Blood Marrow Transplant·2008
4-observational
Nonmyeloablative allogeneic hematopoietic cell transplantation in relapsed, refractory, and transformed indolent non-Hodgkin's lymphoma.
PMID 18056679·J Clin Oncol·2008
4-observational
Five-year follow-up of patients with advanced chronic lymphocytic leukemia treated with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.
PMID 18794548·J Clin Oncol·2008
8-other
Relapse risk in patients with malignant diseases given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.
PMID 17595333·Blood·2007
8-other
Intensive postgrafting immune suppression combined with nonmyeloablative conditioning for transplantation of HLA-identical hematopoietic cell grafts: results of a pilot study for treatment of primary immunodeficiency disorders.
PMID 17660844·Bone Marrow Transplant·2007
3-trial
Extended mycophenolate mofetil and shortened cyclosporine failed to reduce graft-versus-host disease after unrelated hematopoietic cell transplantation with nonmyeloablative conditioning.
PMID 17697966·Biol Blood Marrow Transplant·2007
3-trial
Incidence, risk factors, and pathogenesis of second malignancies in patients with non-Hodgkin lymphoma.
PMID 17701578·Leuk Lymphoma·2007
6-review
A prospective study of G-CSF primed bone marrow as a stem-cell source for allogeneic bone marrow transplantation in children: a Pediatric Blood and Marrow Transplant Consortium (PBMTC) study.
PMID 17827386·Blood·2007
3-trial

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
4650 W SUNSET BLVD, MS# 62
LOS ANGELES, CA 90027

Location

Practice Location

4650 W SUNSET BLVD, LOS ANGELES, CA
(323) 361-2546

Quick Facts

NPI
1932150315
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
4
Locations
1
Publications
20

Are you this provider?

Claim Your Profile